ClinicalTrials.Veeva

Menu

Low Intensity Focused Ultrasound in ASD

Medical University of South Carolina (MUSC) logo

Medical University of South Carolina (MUSC)

Status and phase

Not yet enrolling
Phase 1

Conditions

Autism Spectrum Disorder

Treatments

Device: Active LIFU

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT07225322
5P20GM148302 (U.S. NIH Grant/Contract)
Pro00146822

Details and patient eligibility

About

This study investigates the safety and potential efficacy of personalized, image-guided low intensity focused ultrasound (LIFU) targeting the thalamus in individuals with Autism Spectrum Disorder (ASD). The study evaluates behavioral, neuroimaging, and electrophysiological outcomes following LIFU stimulation using a non-invasive device.

Enrollment

20 estimated patients

Sex

All

Ages

13 to 25 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 13-25
  • Diagnosis of ASD (DSM-5)
  • Full Scale IQ > 70
  • Verbal communication
  • Stable medication for ≥1 month
  • Ability to consent or assent with guardian consent

Exclusion criteria

  • MRI or LIFU contraindications
  • Recent investigational drug/device use
  • Neurological illness (e.g., epilepsy, TBI)
  • Substance use disorder
  • Sensory/motor impairments preventing task completion

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Active LIFU
Experimental group
Treatment:
Device: Active LIFU

Trial contacts and locations

1

Loading...

Central trial contact

Kevin Caulfield, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems